1. Home
  2. GLV vs EDAP Comparison

GLV vs EDAP Comparison

Compare GLV & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clough Global Dividend and Income Fund of beneficial interest

GLV

Clough Global Dividend and Income Fund of beneficial interest

HOLD

Current Price

$6.06

Market Cap

75.2M

Sector

Finance

ML Signal

HOLD

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

N/A

Current Price

$2.33

Market Cap

75.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLV
EDAP
Founded
2004
1979
Country
United States
France
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.2M
75.5M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
GLV
EDAP
Price
$6.06
$2.33
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
54.2K
42.3K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
12.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$74,853,925.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.61
52 Week Low
$4.70
$1.21
52 Week High
$6.06
$3.05

Technical Indicators

Market Signals
Indicator
GLV
EDAP
Relative Strength Index (RSI) 51.52 53.83
Support Level $5.98 $2.11
Resistance Level $6.23 $2.36
Average True Range (ATR) 0.09 0.14
MACD -0.01 0.00
Stochastic Oscillator 51.61 62.16

Price Performance

Historical Comparison
GLV
EDAP

About GLV Clough Global Dividend and Income Fund of beneficial interest

Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: